Science-backed Adaptogens Are Driving The Next Wave Of Pet Calming Products

Fear and stress are no longer just niche concerns in companion animal health. In fact, the global pet calming products market is projected to reach $1.7 billion by 2032, up from $952.4 million in 2024. Demand is accelerating as pet parents look for science-backed solutions to everyday stressors like travel, separation, noise sensitivity, and environmental change. At the same time, they want natural solutions, such as KSM-66 Ashwagandha. After all, it’s the safest and only clinically proven ashwagandha for pets, and now you can find it in a new calming supplement from Boops Pets.

Discover the Latest Calming Pet Product Hitting Store Shelves

Boops Pets is a science-first pet wellness company that delivers evidence-based, human-grade health supplements. Their latest Calming & Stress Relief supplement supports a healthy response to stress while promoting calmness and relaxation. It’s formulated with KSM-66 Ashwagandha, an adaptogenic herb that naturally supports the hypothalamic-pituitary-adrenal axis and healthy cortisol levels. It can encourage calmer behavior, reduce stress and fatigue, and improve resilience. For dogs, that means it’s easier to handle travel, loud noises, and time alone.

Jeffrey Meng, founder of Boops Pets, says this root-only extract is a clear choice for pet calming products. “We approach our supply chain with a zero-compromise policy on traceability and data. After auditing multiple ashwagandha sources, we found KSM-66 Ashwagandha was the only one that offered the batch-to-batch consistency and validated clinical evidence specifically for dogs.”

Meng also cited KSM-66 Ashwagandha’s commitment to fund peer-reviewed animal-specific studies on the herb, which demonstrates a level of responsibility that is rare in the supply chain.

KSM-66 Is a Clinically Studied Adaptogen for Dogs

Long valued in human health, ashwagandha is making measurable inroads into pet formulations today. But clinical validation, safety data, and manufacturing standards vary widely across suppliers. And these are important considerations for brands operating in a more scrutinized regulatory and retail environment.

KSM-66 Ashwagandha is a root-only extract that has been clinically studied specifically in dogs, cats, and horses. It helps reduce cortisol, the body’s primary stress hormone. With 46 certifications covering safety, efficacy, and manufacturing standards, the ingredient offers manufacturers a perfect solution for pet calming products because it’s a clinically proven natural product.

“We’ve long known that ashwagandha can help humans manage stress, and our research shows it can be equally effective for companion animals,” says Kartikeya Baldwa, CEO of Ixoreal Biomed. “We believe all animals can benefit from KSM-66 Ashwagandha’s safe and natural calming powers, and we’re thrilled to partner with Boops Pets, a company dedicated to quality, scientific rigor, and proven pet health supplements that support lifelong wellness.

Functional Benefits That Translate to Formulation Flexibility

From a formulation standpoint, KSM-66 Ashwagandha’s neutral flavor profile supports palatability across delivery formats, including:

• Soft chews
• Functional treats
• Powders
• Capsules
• Food recipes

Its high concentration of withanolides and documented safety profile allow manufacturers to position pet calming products as effective, sustainable, and clinically proven.

For more information, visit ksm66ashwagandhaa.com and boopspets.com

The post Science-Backed Adaptogens Are Driving the Next Wave of Pet Calming Products appeared first on Animal Wellness Magazine.